Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Ayvakyt, avapritinib, Gastrointestinal Stromal Tumors, Date of authorisation: 24/09/2020, Revision: 7, Status: Authorised
TO: